The use of human F(ab') 2  fragments as blocking agents in the mixed lymphocyte reaction.
D000918:Antibody Specificity; D000941:Antigens; D002648:Child; D046508:Culture Techniques; D003601:Cytotoxicity Tests, Immunologic; D005455:Fluorescent Antibody Technique; D005921:Glomerulonephritis / Q000276:immunology; D006084:Graft Rejection; D006648:Histocompatibility; D006801:Humans; D007106:Immune Sera; D007120:Immunochemistry; D005779:Immunodiffusion; D007074:Immunoglobulin G; D007518:Isoantibodies; D016030:Kidney Transplantation; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology* / Q000528:radiation effects; D008297:Male; D008564:Membrane Potentials; D011830:Radiation Effects; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D001743:Urinary Bladder / Q000002:abnormalities
D000941:Antigens; D007106:Immune Sera; D007074:Immunoglobulin G; D007518:Isoantibodies